However, LRRK2-PD neuropathology is variable, ranging from typical Lewy bodies pathology, to pure nigral degeneration, Tau pathology, and progressive supranuclear palsy-like pathology [27], which may reflect the different mode of action of different mutations in combination with other genetic and environmental factors. The gene discussed is MAPT; the disease is progressive supranuclear palsy.